Nutreco invests in Israeli startup to combat shrimp disease more efficiently
Farmed shrimp. (Photo: nutreco)
Nutreco announced it has acquared a minority share in Israeli startup as part of its focus on combatting disease affecting the shrimp aquaculture industry.
This startup, ViAqua, is developing the first orally-administered treatment for shrimp that improves resistance to viral diseases, including white spot syndrome virus (WSSV), and prevents viral epidemics.
The solution offered by the startup uses a proprietary particle to disable viral infections in shrimp, which is intended to be expanded in the future to include more species, like other shellfish such as lobster and crab, and small fish.
Other shareholders in the company include The Trendlines and the Technion – Israel Institute of Technology, both based in Israel.
According to Nutreco’s statement, the investment...